NCT02993302View on ClinicalTrials.gov

Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Graves Disease
Interventions
DRUG

1α-D3

patients were given PTU and 1α-D3

DRUG

Placebos

patients were given PTU and placebos

All Listed Sponsors
collaborator

Indonesia University

OTHER

lead

Dr Cipto Mangunkusumo General Hospital

OTHER

NCT02993302 - Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients | Biotech Hunter | Biotech Hunter